         NOTE: This disposition is nonprecedential.


United States Court of Appeals
    for the Federal Circuit
                      ______________________

    IN RE OMEPRAZOLE PATENT LITIGATION
  --------------------------------------------------------------------------

  ASTRAZENECA AB, AKTIEBOLAGET HASSLE,
  KBI-E, INC., KBI, INC., AND ASTRAZENECA LP,
                Plaintiffs-Appellees,

                                     v.

  MYLAN LABORATORIES INC. (now known as
 Mylan Inc.), MYLAN PHARMACEUTICALS INC.,
 LABORATORIOS DR. ESTEVE, S.A. and ESTEVE
                  QUIMICA, S.A.,
               Defendants-Appellants.
               ____________________

                            2010-1414
                      ______________________

   Appeal from the United States District Court for the
Southern District of New York in Nos. 00-CV-6749, 03-
CV-6057, M-21-81, and MDL no. 1291, Judge Barbara S.
Jones.
                ______________________

                           JUDGMENT
                      ______________________

   ERROL B. TAYLOR, Milbank, Tweed, Hadley & McCloy
LLP, of New York, New York, argued for plaintiffs-
appellees. With him on the brief were FREDRICK M.
ZULLOW, JOHN M. GRIEM, JR., and CHRISTOPHER J.
GASPAR.
   JAMES H. WALLACE, JR., Wiley Rein, LLP, of
Washington, DC, argued for defendants-appellants. With
him on the brief were MARK A. PACELLA and BRIAN H.
PANDYA.
                ______________________

THIS CAUSE having been heard and considered, it is

ORDERED and ADJUDGED:

   PER CURIAM (RADER, Chief Judge, MOORE and
O’MALLEY, Circuit Judges).


AFFIRMED. See Fed. Cir. R. 36.

                      ENTERED BY ORDER OF THE COURT



March 8, 2011          /s/ Jan Horbaly
   Date                        Jan Horbaly
                                   Clerk
